Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Canopy Growth Corp (CGC) Financial Statements

Canopy Growth Corp (CGC) reported trailing twelve-month revenue of $293.6M (up 6.8% year on year) and net income of -$232.6M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$83.2M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CGCCanopy Growth CorpFollow CGC — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
285.9M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
6 Nov, in 13 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2020
Mar 20
FY2021
Mar 21
FY2022
Mar 22
FY2023
Mar 23
FY2024
Mar 24
FY2025
Mar 25
FY2026
Mar 26
TTM
Jun 26
Trend
Revenue398.8546.6475.7333.3297.1269.0284.6293.6
Gross profit-31.767.0-187.4-63.580.979.569.773.9
Research & development61.857.632.321.74.62.72.6—
Operating income-1,669.0-1,243.5-1,018.8-2,630.5-228.7-117.1-161.7-161.1
Pre-tax income-1,509.1-1,684.0-267.9-3,086.2-507.8-507.8-262.9-233.0
Income tax-121.6-13.1-8.9-5.712.37.10.0-0.4
Net income-1,321.3-1,744.9-310.0-3,278.2-693.7-508.9-262.9-232.6
Diluted EPS ($)-3.80-4.69-0.77—-9.27-4.73-0.88-0.55
Diluted shares (mn)———46.474.8107.6298.0—

USD millions · SEC XBRL

Canopy Growth Corp — questions

What is Canopy Growth Corp's revenue?
$293.6M over the twelve months to 2026-06-30, up 6.8% year on year, from its 10-Q and 10-K filings.
What is Canopy Growth Corp's net income?
-$232.6M over the twelve months to 2026-06-30.
What is Canopy Growth Corp's free cash flow?
-$83.2M over the twelve months to 2026-06-30.
What are Canopy Growth Corp's diluted earnings per share?
$-0.55 over the twelve months to 2026-06-30.

Every figure on this page comes from Canopy Growth Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.